THE BEST SIDE OF (+)-JQ-1 MECHANISM OF ACTION

Semaglutide, a glucagon like peptide-1 (GLP-one) receptor agonist, is available as monotherapy in equally subcutaneous together with oral dosage variety (first authorized oral GLP-one receptor agonist). It has been approved as being a second line remedy choice for superior glycaemic Command in form 2 diabetic issues and now below scrutiny for anti-